← Back to home

GROUP 4: 4-8 YO CF PARTICIPANTS STARTING TRIPLE COMBINATION MODULATOR THERAPY

Clinical trials for GROUP 4: 4-8 YO CF PARTICIPANTS STARTING TRIPLE COMBINATION MODULATOR THERAPY explained in plain language.

Never miss a new study

Get alerted when new GROUP 4: 4-8 YO CF PARTICIPANTS STARTING TRIPLE COMBINATION MODULATOR THERAPY trials appear

Sign up with your email to follow new studies for GROUP 4: 4-8 YO CF PARTICIPANTS STARTING TRIPLE COMBINATION MODULATOR THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

MRI scans could offer new window into cystic fibrosis treatment effects

Knowledge-focused Ongoing

This study aims to see if MRI scans can detect changes in the lungs of people with cystic fibrosis who are receiving new CFTR-modulator treatments. Researchers will compare MRI results to standard breathing tests and quality of life measures over several years. The study includes…

Matched conditions: GROUP 4: 4-8 YO CF PARTICIPANTS STARTING TRIPLE COMBINATION MODULATOR THERAPY

Sponsor: The Hospital for Sick Children • Aim: Knowledge-focused

Last updated Apr 01, 2026 14:41 UTC

GROUP 4: 4-8 YO CF PARTICIPANTS STARTING TRIPLE COMBINATION MODULATOR THERAPY

Get alerted when new GROUP 4: 4-8 YO CF PARTICIPANTS STARTING TRIPLE COMBINATION MODULATOR THERAPY trials appear

MRI scans could offer new window into cystic fibrosis treatment effects